Could A COVID Vaccine Kill Silver And Gold?
Peter Krauth | Nov 10, 2020 04:02PM ET
Believe it or not, the big deal for precious metals this week was not the U.S. Election.
It was news that Pfizer (NYSE:PFE) and BioNtech's (NASDAQ:BNTX) COVID-19 vaccine was over 90% effective in preventing the virus, and would likely be among the first to receive FDA authorization.
Monday was massively risk-on, with the Dow soaring 4% to a new record high, 10-year treasuries yields shot up almost 17% in a single day as investors dumped bonds, and oil was ahead 8%.
Meanwhile, the U.S dollar index gained about 60 basis points or 0.65%, while higher-beta currencies jumped.
Gold and silver both sold off quite strongly and stayed near their lower price levels.
Naturally, some gold and silver enthusiasts are asking themselves if a vaccine is enough to kill the COVID-19 virus, as well as the precious metals bull market.
And based on the initial reaction of these metals, it’s a natural question.
So let’s look at the implications.
Is The Gold and Silver Party Over?/h2
The encouraging news everyone’s been waiting for appears to finally be here. We’re getting a glimpse of light from the end of this long tunnel.
As a result, gold dropped $84 or 4.3%, while silver lost 5.3%, on this news.
But is this a sign of things to come, or a knee-jerk reaction that’s just short sighted?
Although highly positive and very reassuring, the truth is we’re not going to be lining up tomorrow to get our first of two doses of Pfizer’s vaccine.
The road to normalcy, whatever that will mean, is still a long one.
Consider that Pfizer expects to only produce 50 million doses this year, and up to 1.3 billion in 2021. Logistics will be a challenge, as the vaccine will need to be stored at -70 degrees Celsius, which is much colder than other vaccines.
Storage, transportation, logistics, security, and prioritization will all be complex. The first to receive the vaccine will be higher risk people and healthcare providers. Two doses, 21 days apart, are required.
Basically, it’s going to take quite some time to get this vaccine rolled out and administered even in developed nations. Imagine for a moment what that might look like in developing ones. That could keep travel and other sectors, that can’t easily implement social distancing, from recovering early.
And I’ve barely scratched the surface of challenges brought on by a vaccine roll-out.
The Solution May Only Exacerbate Things/h2
Realistically, COVID-19 is a long way from being a distant memory.
Restricted movement, quiet cities, empty restaurants, cinemas and gyms, and mostly local tourism. Daily life will continue to trudge forward.
Unfortunately, that also includes the world’s ongoing geopolitical tensions. I don’t see relations between the two biggest economies, the U.S. and China, cozying up anytime soon, as both sides want to continue “looking tough”.
We know the Fed has promised to keep rates near zero through 2023 to support economic recovery. They also vowed to let inflation “run hot” above 2% to make up for years of anemic levels.
Debts and deficits are going to continue to soar. Even with a Republican-led Senate, Biden’s still likely to get a $500 billion to $1 trillion “skinny stimulus” bill passed early next year. Though well under the $3 trillion bill passed in May, Goldman Sachs (NYSE:GS) says this would still be nearly 5% of GDP.
Gold and Silver Still Strong/h2
In my view, gold and silver simply had not finished correcting after gold established an all-time record high in August.
Sentiment is a tricky market driver to navigate.
But one thing is fairly clear, gold and silver hedgers (smart money) have not yet flipped to a bullish stance.
They remain cautious right now on gold.
And as for silver, they appear to be stuck in neutral.
If anything, the selloff may be the catalyst many have been waiting for to help gold and silver establish a bottom, or at least an end to their consolidation.
I believe Pfizer’s positive vaccine news may only have dented precious metals for a short time, as it scared some weak hands out of the sector.
Odds are smart money is going to start buying the dips and accumulate gold and silver, as it gears up for the next, inevitable rally.
Don’t be short-sighted.
After all, it’s going to take a lot more than a vaccine that kills COVID-19, to also kill silver and gold.
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.